We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
+$259M
(+4.2%)
Cap. Flow
+$227M
Cap. Flow
% of AUM
3.52%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$330M |
| 2 |
Brookdale Senior Living
BKD
|
+$93.7M |
| 3 |
Tenet Healthcare
THC
|
+$85.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$70.6M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$206M |
| 2 |
CVS Health
CVS
|
+$122M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$102M |
| 4 |
McKesson
MCK
|
+$80.6M |
| 5 |
Pacira BioSciences
PCRX
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.08% |
| 2 | Miscellaneous | 9.89% |
| 3 | Energy | 6.47% |
| 4 | Consumer Discretionary | 5.67% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESL
751
DELISTED
Esterline Technologies
ESL
| $446K | 0.01% |
+3,872
| New | +$427K |
|
|
BCPC
752
Balchem Corp
BCPC
$5.34B
| $442K | 0.01% |
+8,244
| New | +$473K |
|
|
ACAS
753
DELISTED
American Capital Ltd
ACAS
| $441K | 0.01% |
+28,836
| New | +$430K |
|
754
BCE
BCE
$21B
| $440K | 0.01% |
9,700
-8,000
| -45% | -$360K |
|
755
Archer Daniels Midland
ADM
$41B
| $438K | 0.01% |
9,937
-2,463
| -20% | -$109K |
|
|
ALJ
756
DELISTED
Alon USA Energy Inc
ALJ
| $438K | 0.01% |
+35,193
| New | +$524K |
|
757
Andersons Inc
ANDE
$2.43B
| $437K | 0.01% |
+8,472
| New | +$466K |
|
758
FTI Consulting
FCN
$4.01B
| $437K | 0.01% |
+11,548
| New | +$381K |
|
|
ARX
759
DELISTED
Aeroflex Holding Corp (DE)
ARX
| $437K | 0.01% |
+41,613
| New | +$384K |
|
760
Brink's
BCO
$4.47B
| $434K | 0.01% |
15,376
+7,710
| +101% | +$207K |
|
|
PPO
761
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
| $433K | 0.01% |
+9,072
| New | +$372K |
|
762
Intuitive Surgical
ISRG
$135B
| $432K | 0.01% |
9,450
-773,415
| -99% | -$34.1M |
|
|
CYS
763
DELISTED
CYS Investments Inc.
CYS
| $432K | 0.01% |
47,860
+33,929
| +244% | +$300K |
|
764
MidCap Financial Investment
MFIC
$745M
| $431K | 0.01% |
16,695
+12,693
| +317% | +$313K |
|
765
Dana Inc
DAN
$3.22B
| $430K | 0.01% |
17,618
-39,433
| -69% | -$884K |
|
|
SF
766
Stifel
SF
$11.4B
| $427K | 0.01% |
+20,297
| New | +$418K |
|
|
CTB
767
DELISTED
Cooper Tire & Rubber Co.
CTB
| $427K | 0.01% |
+14,229
| New | +$387K |
|
768
Columbia Sportswear
COLM
$2.92B
| $426K | 0.01% |
10,312
+5,368
| +109% | +$224K |
|
769
Pilgrim's Pride
PPC
$7.06B
| $426K | 0.01% |
+15,579
| New | +$370K |
|
770
Cboe Global Markets
CBOE
$28.2B
| $425K | 0.01% |
+8,633
| New | +$438K |
|
771
First Financial Bankshares
FFIN
$4.78B
| $425K | 0.01% |
+27,074
| New | +$409K |
|
772
Jefferies Financial Group
JEF
$10.9B
| $424K | 0.01% |
+18,059
| New | +$419K |
|
773
Clean Harbors
CLH
$16.8B
| $423K | 0.01% |
+6,581
| New | +$391K |
|
774
Erie Indemnity
ERIE
$12.8B
| $423K | 0.01% |
+5,625
| New | +$415K |
|
775
New Jersey Resources
NJR
$5.43B
| $423K | 0.01% |
+14,796
| New | +$385K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Visium Asset Management deployed $227M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 56% a quarter earlier, followed by Miscellaneous and Energy.
On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.
- Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
- Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
- Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
- Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
- Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
- Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
- Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.
Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.